(Press-News.org) HONOLULU – A new drug called perampanel appears to significantly reduce seizures in people with hard-to-control epilepsy, according to results of the first clinical trial to test the higher 12 mg dose of the drug. The late-breaking research will be presented at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, in Honolulu.
"For about one-third of people with epilepsy, the drugs either don't stop their seizures or the side effects are not tolerable," said study author Jacqueline French, MD, with New York University in New York. French is also a Fellow of the American Academy of Neurology. "If this drug is approved by the Food and Drug Administration (FDA), it will be another tool in our arsenal for combating or reducing seizures in people with difficult to treat epilepsy."
The study involved 387 people in the United States and Latin America who had uncontrolled epilepsy and were currently taking one to three other anti-seizure drugs. Participants were assigned to receive either eight or 12 milligrams of perampanel or a placebo pill once daily for 19 weeks in addition to their regular treatment.
Patients who took the 12 milligram dose of perampanel had a 14-percent reduction in seizures in a 28-day period compared to those who took the placebo. Those who took the eight milligram dose cut their seizure frequency by nearly six percent compared to those who took the placebo.
The most common side effects of the drug were dizziness, drowsiness, irritability, headache, falls and ataxia, which is a lack of muscle coordination.
"These findings provide further evidence of the effectiveness and safety of perampanel as an added treatment option to reduce seizures," said French. "Plans are to submit the drug for FDA approval this year."
###
The study was supported by Eisai Inc.
The American Academy of Neurology, an association of more than 22,500 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care.
A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, epilepsy and Parkinson's disease. For more information about the American Academy of Neurology and its upcoming Annual Meeting, visit http://www.aan.com.
Editor's Note:
Dr. French will be available for media questions during a press conference at 5:00 p.m. ET/11:00 a.m. HST, on Tuesday, April 12, 2011, in Room 325B of the Hawaii Convention Center in Honolulu. Please contact Rachel Seroka, rseroka@aan.com, to receive conference call information for those reporters covering the press conference off-site.
Dr. French is available for advance interviews as well. Please contact Rachel Seroka, rseroka@aan.com, to schedule an advance interview.
To access non-late-breaking abstracts to be presented at the 2011 AAN Annual Meeting, visit http://www.aan.com/go/am11/science. Late-breaking abstracts will not be posted online in advance of the meeting and are embargoed until the date and time of presentation at the AAN Annual Meeting in Honolulu or unless otherwise noted by the Academy's Media and Public Relations Department.
The American Academy of Neurology, an association of more than 22,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia.
For more information about the American Academy of Neurology, visit http://www.aan.com.
VIDEO:
http://www.youtube.com/AANChannel
TEXT:
http://www.aan.com/press
TWEETS:
http://www.twitter.com/AANPublic
END
WASHINGTON, DC – Walking on a treadmill for one hour a day may slow the progression of nonalcoholic fatty liver disease in obese people with prediabetes by jump-starting their metabolism and slowing the oxidative damage wrought by the condition, say researchers at the Cleveland Clinic. A study of 15 obese people with nonalcoholic fatty liver disease revealed that the daily walks not only increase insulin sensitivity, but improve the liver's polyunsaturated lipid index (PUI), which is thought to be a marker of liver health.
The improvements are linked to an increase in ...
CHICAGO – Subtle differences in brain anatomy among older individuals with normal cognitive skills may be able to predict both the risk of developing Alzheimer's disease in the following decade and how quickly symptoms of dementia would develop. In their analysis of magnetic resonance (MR) images from two separate study groups, researchers from Rush University Medical Center and Massachusetts General Hospital (MGH) found that, among individuals in whom specific brain structures were thinnest, the risk of developing Alzheimer's was three times greater than in those with ...
ST. PAUL, Minn.–Areas of the brain affected by Alzheimer's disease may start shrinking up to a decade before dementia is diagnosed, according to a new study published in the April 13, 2011, issue of Neurology®, the medical journal of the American Academy of Neurology.
For the study, researchers used MRI scans to measure areas of the brain in people with no memory problems or other signs of Alzheimer's, then followed them for years to see who developed the disease. The researchers specifically focused their measurements on areas known to be involved in AD. Those with ...
ST. PAUL, Minn. – Treating high blood pressure, high cholesterol, diabetes and other vascular risk factors may help lower the risk of Alzheimer's disease in people who already show signs of declining thinking skills or memory problems. The research is published in the April 13, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers followed 837 people with mild cognitive impairment, the stage of memory loss that often leads to Alzheimer's disease. Of the group, 414 had at least one vascular risk factor. Participants were ...
Rett syndrome, a neurodevelopmental disorder on the autism spectrum, is marked by relatively normal development in infancy followed by a loss of loss of cognitive, social and language skills starting at 12 to 18 months of age. It is increasingly seen as a disorder of synapses, the connections between neurons that together form brain circuits. What hasn't been clear is why children start out developing normally, only to become progressively abnormal. New research from Children's Hospital Boston, published in the April 14 issue of Neuron, helps unravel what's going on.
The ...
WASHINGTON – Approximately one million Americans suffer a heart attack each year of which some 400,000 attacks are fatal. A key cause of heart attacks is atherosclerosis, a process in which cholesterol builds up in the arteries and impedes the ability of the blood to flow to our most vital organ. Atherosclerosis is often associated with a high-fat diet in humans, but in a new study using an animal model researchers have found that a high-fat diet for a very short period can protect the heart from heart attacks and result in less tissue damage when heart attacks occur. ...
WASHINGTON – Walking on a treadmill for one hour a day may slow the progression of nonalcoholic fatty liver disease in obese people with prediabetes by jump-starting their metabolism and slowing the oxidative damage wrought by the condition, say researchers at the Cleveland Clinic. A study of 15 obese people with nonalcoholic fatty liver disease revealed that the daily walks not only increase insulin sensitivity, but improve the liver's polyunsaturated lipid index (PUI), which is thought to be a marker of liver health.
The improvements are linked to an increase in the ...
CINCINNATI—A new study from researchers at the University of Cincinnati (UC) shows that short-term, high-fat "splurges" within one's diet could elicit cardioprotective properties during a heart attack.
These findings are being presented for the first time at the 2011 Experimental Biology Meeting sponsored by the American Society for Pharmacology and Experimental Therapeutics on April 13 in Washington, D.C.
Lauren Haar, a doctoral student in the Systems Biology and Physiology Graduate Program, found that short-term, high-fat feeding in animal models led to cardioprotection ...
GRAND RAPIDS, MICH., April 13, 2011 – Although only one in 10 American adults eats enough fruits and vegetables (1), new research being presented at the Experimental Biology meeting this week in Washington, D.C., finds older adults are consuming higher levels of carotenoids, flavonoids and other phytonutrients found in fruits and vegetables that are thought to support healthy aging. Specifically, the new findings suggest that, calorie for calorie, intakes of carotenoids are 20 percent higher, flavonoids 40 percent higher, and ellagic acid is 80 percent higher among older ...
ROCHESTER, Minn. -- A new research study of the effect of a commonly used strategy to reduce the spread of antibiotic-resistant bacteria in hospital intensive care units (ICU) shows that the strategy had no significant effect. That's the surprising finding of a multisite study led by Mayo Clinic investigators. The bacteria -- methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) -- are resistant to common antibiotics and harder to treat if patients become infected. The findings appear in today's New England Journal of Medicine (http://www.nejm.org/).
The ...
